4//SEC Filing
Vivo Capital Fund VIII, L.P. 4
Accession 0001213900-22-054888
CIK 0001831363other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 8:00 PM ET
Size
13.7 KB
Accession
0001213900-22-054888
Insider Transaction Report
Form 4
Vivo Opportunity, LLC
10% Owner
Transactions
- Purchase
Common Stock
2022-09-07$3.60/sh+600,000$2,160,000→ 3,581,592 total(indirect: By Vivo Opportunity Fund Holdings, L.P.)
Holdings
- 2,036,557(indirect: By: Vivo Capital Fund VIII, L.P.)
Common Stock
- 281,223(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Common Stock
Vivo Capital VIII, LLC
10% Owner
Transactions
- Purchase
Common Stock
2022-09-07$3.60/sh+600,000$2,160,000→ 3,581,592 total(indirect: By Vivo Opportunity Fund Holdings, L.P.)
Holdings
- 2,036,557(indirect: By: Vivo Capital Fund VIII, L.P.)
Common Stock
- 281,223(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Common Stock
Vivo Capital Fund VIII, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2022-09-07$3.60/sh+600,000$2,160,000→ 3,581,592 total(indirect: By Vivo Opportunity Fund Holdings, L.P.)
Holdings
- 281,223(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Common Stock
- 2,036,557(indirect: By: Vivo Capital Fund VIII, L.P.)
Common Stock
Vivo Opportunity Fund Holdings, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2022-09-07$3.60/sh+600,000$2,160,000→ 3,581,592 total(indirect: By Vivo Opportunity Fund Holdings, L.P.)
Holdings
- 2,036,557(indirect: By: Vivo Capital Fund VIII, L.P.)
Common Stock
- 281,223(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Common Stock
Vivo Capital Surplus Fund VIII, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2022-09-07$3.60/sh+600,000$2,160,000→ 3,581,592 total(indirect: By Vivo Opportunity Fund Holdings, L.P.)
Holdings
- 2,036,557(indirect: By: Vivo Capital Fund VIII, L.P.)
Common Stock
- 281,223(indirect: By: Vivo Capital Surplus Fund VIII, L.P.)
Common Stock
Footnotes (1)
- [F1]Vivo Opportunity, LLC is the general partner of Vivo Opportunity Fund Holdings, L.P., the record holder of the securities. Gaurav Aggarwal, Hongbo Lu, Kevin Dai, Frank Kung and Michael Chang are managing members of Vivo Opportunity, LLC and may be deemed to share voting and dispositive power over the securities held by Vivo Opportunity Fund Holdings, L.P. Each of these individuals disclaims beneficial ownership over such securities except to the extent of his or her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Documents
Issuer
Terns Pharmaceuticals, Inc.
CIK 0001831363
Entity typeother
Related Parties
1- filerCIK 0001618788
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 8:00 PM ET
- Size
- 13.7 KB